November 2024 in returns
November 2024 produced the single broadest advance in this entire record, and it was crypto that made it extraordinary. 79 of 80 coins finished green — 99% participation, a figure no other month approaches. Bitcoin rose 37.1%, Ethereum 47.0% and Solana 40.9%, but the majors were the modest part of it: Stellar gained 468.2%, Algorand 288.3%, XRP 282.9%, Hedera 267.3%, Cardano 215.7% and Sandbox 174.5%. Equities joined without hesitation — the Russell 2000 up 10.8%, the Dow 7.5%, the Nasdaq 6.2% — with 620 of 866 stocks (72%) higher and the VIX collapsing 41.7%.
The equity leaders were the same high-beta complex October had been accumulating, now paid off in full: Rocket Lab +154.9%, AppLovin +98.8%, Coinbase +65.2%, Palantir +61.4%, Robinhood +59.8%, MicroStrategy +58.5%. Almost nothing fell, and what did was defensive or foreign — Monolithic Power -25.2%, Bayer -21.8%, Moderna -20.8%. Whatever the trigger, the response was uniform rather than selective, which is what separates a repricing of risk appetite itself from a rotation between sectors. Months like this are exhilarating and rarely repeat; the hangover arrived immediately, and the coins that led here would spend most of 2025 giving it back.
Get next month’s recap by email
Headline moves
Breadth: 81 of 82 top-250 coins (99%) and 634 of 881 stocks/indices (72%) finished the month green.
Counts are the assets with a completed return for November 2024— not the current universe. Crypto breadth is measured over coins ranked in the top 250 by market cap, because a thin micro-cap's return says more about its float than about the market; the stock count is not capped, so the two percentages describe different universes. The crypto count also moves month to month as coins enter and exit that top 250, and new listings and delistings shift the equity count the same way.
Top crypto ▲ (over $5b)
Top crypto ▲ (top 250)
Worst crypto ▼ (top 250)
- XAUT -3.5%
Biggest single large-cap move this month: BE (Bloom Energy) at +186%. This is a look back at the numbers, not financial advice — see our Terms.